Typical features of the etiology, pathogenesis and pathological morphology of chronic obstructive pulmonary disease in women and men
https://doi.org/10.18093/0869-0189-2021-31-4-530-536
Abstract
Chronic obstructive pulmonary disease (COPD) is a highly debilitating disease that poses a significant and increasing burden on women’s health. There is an increasing amount of information about gender-related differences in risk factors and the progression of COPD. However, very little attention is paid in scientific research and practice to COPD as a significant issue of women’s health. The challenges of COPD prevention in women can be overcome by a multi-vector approach, including increasing patient awareness of the disease, reducing the risk of its occurrence and further research on gender aspects (biological and cultural) that affect the risk of development and the rate of progression of COPD. The article reviews the current literature on this issue.
About the Author
F. T. Malykhin
Stavropol State Medical University, Healthcare Ministry of Russia
Russian Federation
Competing Interests:
Russian Federation
Fedor T. Malykhin, Candidate of Medicine, Associate Professor, Department of Propaedeutics of Internal Diseases
ul. Mira 310, Stavropol, 355017
Competing Interests:
no
References
1. Soe A.K., Avdeev S.N., Nuralieva G.S et al. [Predictors of poor outcomes in acute exacerbations of chronic obstructive pulmonary disease]. Pul’monologiya. 2018; 28 (4): 446–452. DOI: 10.18093/0869-0189-2018-28-4-446-452 (in Russian).
2. Jenkins C.R., Chapman K.R., Donohue J.F. et al. Improving the management of COPD in women. Chest. 2017; 151 (3): 686–696. DOI: 10.1016/j.chest.2016.10.031.
3. Malykhin F., Khripunova А. Medical and demographic loss of population due to chronic obstructive pulmonary disease. Eur. Respir. J. 2016; 48 (Suppl. 60): PA3929. DOI: 10.1183/13993003.congress-2016.PA3929.
4. Malykhin F.T., Khripunova A.A. [A study of gender and age-related aspects of medicodemographic losses of the population of Stavropol as a result of chronic obstructive pulmonary disease]. Spravochnik vracha obshchey praktiki. 2014; (3): 33–37 (in Russian).
5. World Health Organization. Chronic respiratory disease. Available at: http://www.who.int/respiratory/copd/en/ [Accessed: January 15, 2020].
6. Aryal S., Diaz-Guzman E., Mannino D. Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes. Int. J.Chron. Obstruct.Pulmon. Dis. 2014; 9 (1): 1145–1154. DOI: 10.2147/COPD.S54476.
7. Malykhin F.T., Khripunova A.A., Baturin V.A. [Assessment of costs of the health care system for chronic obstructive pulmonary disease in the Stavropol region]. Klinicheskaya gerontologiya. 2015; 21 (11-12): 93–95. Available at: https://kg.newdiamed.ru/issue/id9106/id11870 (in Russia).
8. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: 2019 Report. Available at: https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.7-FINAL-14Nov2018-WMS.pdf [Accessed: January 19, 2020].
9. López-Campos J.L., Ruiz-Ramos M., Soriano J.B. Mortality trends in chronic obstructive pulmonary disease in Europe, 1994–2010: a joinpoint regression analysis. Lancet Respir. Med. 2014; 2 (1): 54–62. DOI: 10.1016/S2213-2600(13)70232-7.
10. Malykhin F.T., Kostornaya I.V., Gordeeva L.P. [Age aspects of comorbidity in the pathology of respiratory bodies by data of pathologyanatomic research]. Klinicheskaya gerontologiya. 2018; 24 (9-10): 39–41. Available at: https://cyberleninka.ru/article/n/vozrastnye-aspekty-komorbidnosti-patologii-organov-dyhaniya-po-rezultatam-patologoanatomicheskih-issledovaniy/viewer (in Russian).
11. Ancochea J., Miravitlles M., García-Río F. et al. Underdiagnosis of chronic obstructive pulmonary disease in women: quantification of the problem, determinants and proposed actions. Arch. Bronconeumol. 2013; 49 (6): 223–229. DOI: 10.1016/j.arbres.2012.11.010 (in English, Spanish).
12. Malykhin F.T. [Indicators of comorbidity in chronic broncho-obstructive pathology]. Uspekhi gerontologii. 2017; 30 (1): 143–148. Available at: http://www.gersociety.ru/netcat_files/userfiles/10/AG_2017-30-01_.pdf (in Russian).
13. Jordan R.E., Miller M.R., Lam K.H. et al. Sex, susceptibility to smoking and chronic obstructive pulmonary disease: the effect of different diagnostic criteria. Analysis of the Health Survey for England. Thorax. 2012; 67 (7): 600–605. DOI: 10.1136/thoraxjnl-2011-201384.
14. Rahmanian S.D., Diaz P.T., Wewers M.E. Tobacco use and cessation among women: research and treatment-related issues. J. Womens Health (Larchmt.). 2011; 20 (3): 349–357. DOI: 10.1089/jwh.2010.2173.
15. Sørheim I.C., Johannessen A., Gulsvik A. et al. Gender differences in COPD: are women more susceptible to smoking effects than men? Thorax. 2010; 65 (6): 480–485. DOI: 10.1136/thx.2009.122002.
16. Hardin M., Foreman M., Dransfield M.T. et al. Sex-specific features of emphysema among current and former smokers with COPD. Eur. Respir. J. 2016; 47 (1): 104–112. DOI: 10.1183/13993003.00996-2015.
17. Prescott E., Bjerg A.M., Andersen P.K. et al. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur. Respir. J. 1997; 10 (4): 822–827.
18. Malykhin F.T., Kostornaya I.V. [Morphological changes in the respiratory organs in chronic obstructive pulmonary disease]. Arkhiv patologii. 2016; 78 (1): 42–50. Available at: https://www.mediasphera.ru/issues/arkhiv-patologii/2016/1/downloads/ru/1000419552016011042 (in Russian).
19. World Health Organization. Empower women. Combating tobacco industry marketing in the WHO European region. Available at: http://www.euro.who.int/__data/assets/pdf_file/0014/128120/e93852.pdf [Accessed: January 19, 2020].
20. Goel S., Tripathy J.P., Singh R.J., Lal P. Smoking trends among women in India: Analysis of nationally representative surveys (1993–2009). South Asian J. Cancer. 2014; 3 (4): 200–202. DOI: 10.4103/2278-330X.142958.
21. Hitchman S.C., Fong G.T. Gender empowerment and female-tomale smoking prevalence ratios. Bull. World Health Organ. 2011; 89 (3): 195–202. DOI: 10.2471/BLT.10.079905.
22. Malykhin F.Т. [Studying of smoking prevalence value among elderly patients with chronic lung diseases for indicators of external respiration function]. Izvestiya Samarskogo nauchnogo tsentra Rossiyskoy akademii nauk. 2012; 14 (5-2): 561–563. Available at: http://www.ssc.smr.ru/media/journals/izvestia/2012/2012_5_561_563.pdf (in Russian).
23. Salvi S.S., Barnes P.J. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009; 374 (9691): 733–743. DOI: 10.1016/S0140-6736(09)61303-9.
24. The Tobacco Atlas. Available at: https://tobaccoatlas.org/ [Accessed: January 19, 2020].
25. Rycroft C.E., Heyes A., Lanza L., Becker K. Epidemiology of chronic obstructive pulmonary disease: a literature review. Int. J. Chron. Obstruct. Pulmon. Dis. 2012; 7: 457–494. DOI: 10.2147/COPD.S32330.
26. World Health Organization. Gender, health and tobacco. Available at: http://www.who.int/gender/documents/Gender_Tobacco_2.pdf [Accessed: January 19, 2020].
27. Vozoris N.T., Stanbrook M.B. Smoking prevalence, behaviours, and cessation among individuals with COPD or asthma. Respir. Med. 2011; 105 (3): 477–484. DOI: 10.1016/j.rmed.2010.08.011.
28. Jain N.K., Thakkar M.S., Jain N. et al. Chronic obstructive pulmonary disease: Does gender really matter? Lung India. 2011; 28 (4): 258–262. DOI: 10.4103/0970-2113.85686.
29. Gordon S.B., Bruce N.G., Grigg J. et al. Respiratory risks from household air pollution in low and middle income countries. Lancet Respir. Med. 2014; 2 (10): 823–860. DOI: 10.1016/S2213-2600(14)70168-7.
30. Tan W.C., Sin D.D., Bourbeau J. et al. Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study. Thorax. 2015; 70 (9): 822–829. DOI: 10.1136/thoraxjnl-2015-206938.
31. Camp P.G., Ramirez-Venegas A., Sansores R.H. et al. COPD phenotypes in biomass smoke versus tobacco smoke-exposed Mexican women. Eur. Respir. J. 2014; 43 (3): 725–734. DOI: 10.1183/09031936.00206112.
32. Dal Negro R.W., Bonadiman L., Turco P. Prevalence of different comorbidities in COPD patients by gender and GOLD stage. Multidiscip. Respir. Med. 2015; 10 (1): 24. DOI: 10.1186/s40248-015-0023-2.
33. Po J.Y.T., FitzGerald J.M., Carlsten C. Respiratory disease associated with solid biomass fuel exposure in rural women and children: systematic review and meta-analysis. Thorax. 2011; 66 (3): 232–239. DOI: 10.1136/thx.2010.147884.
34. Golpe R., Sanjuán López P., Cano Jiménez E. et al. Distribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smoke. Arch. Bronconeumol. 2014; 50 (8): 318–324. DOI: 10.1016/j.arbres.2013.12.013 (in English, Spanish).
35. Han M.K. The “other” COPD. Eur. Respir. J. 2014; 43 (3): 659–661. DOI: 10.1183/09031936.00169913.
36. Blanc P.D., Iribarren C., Trupin L. et al. Occupational exposures and the risk of COPD: dusty trades revisited. Thorax. 2009; 64 (1): 6–12. DOI: 10.1136/thx.2008.099390.
37. Roy S., Dasgupta A. A study on health status of women engaged in a home-based “Papad-making” industry in a slum area of Kolkata. Indian J. Occup. Environ. Med. 2008; 12 (1): 33–36. DOI: 10.4103/0019-5278.40814.
38. World Health Organization. Gender, Work and Health. Available at: http://apps.who.int/iris/bitstream/10665/97940/1/9789241501729_eng.pdf [Accessed: January 19, 2020].
39. Burney P.G.J., Patel J., Newson R. et al. Global and regional trends in COPD mortality, 1990–2010. Eur. Respir. J. 2015; 45 (5): 1239–1247. DOI: 10.1183/09031936.00142414.
40. Gershon A.S., Dolmage T.E., Stephenson A., Jackson B. Chronic obstructive pulmonary disease and socioeconomic status: a systematic review. COPD. 2012; 9 (3): 216–226. DOI: 10.3109/15412555.2011.648030.
41. Sommer I., Griebler U., Mahlknecht P. et al. Socioeconomic inequalities in non-communicable diseases and their risk factors: an overview of systematic reviews. BMC Public Health. 2015; 15: 914. DOI: 10.1186/s12889-015-2227-y.
42. UN Women. Facts and Figures: Economic Empowerment. Benefits of economic empowerment. Available at: https://www.unwomen.org/en/what-we-do/economic-empowerment/facts-and-figures [Accessed: January 19, 2020].
43. Baturin V.A., Malykhin F.T. [Assessment of current practice of antibiotic therapy of respiratory infections according to the survey of physicians and analysis of medical records]. Problemy standartizatsii v zdravookhranenii. 2012; (1-2): 42–46 (in Russian).
44. Baturin V.A., Malykhin F.T., Shchetinin E.V. [Composition of microorganisms, discharged from the sputum in patients with lower respiratory tract infections, and their sensitivity to antibacterial drugs depending on age of the patients, diagnosis and previous treatment]. Profilakticheskaya i klinicheskaya meditsina. 2012; 2: 48–51. Available at: https://profclinmed.szgmu.ru/index.php?page=journ_old (in Russian).
45. Byrne A.L., Marais B.J., Mitnick C.D. et al. Tuberculosis and chronic respiratory disease: a systematic review. Int. J. Infect. Dis. 2015; 32: 138–146. DOI: 10.1016/j.ijid.2014.12.016.
46. Dai M.Y., Qiao J.P., Xu Y.H., Fei G.H. Respiratory infectious phenotypes in acute exacerbation of COPD: an aid to length of stay and COPD Assessment Test. Int. J. Chron. Obstruct. Pulmon. Dis. 2015; 10 (1): 2257–2263. DOI: 10.2147/COPD.S92160.
47. Baturin V.A., Shchetinin E.V., Malykhin F.T. Regional specifics of microbial landscape in outpatients with lower respiratory tract infections. Int. J. Risk Saf. Med. 2015; 27 (Suppl. 1): S61–62. DOI: 10.3233/JRS-150691.
48. Malykhin F.T., Baturin V.A., Shchetinin E.V. [Comparison of microflora of the pharynx and sputum in patients with infections of respiratory system]. Kubanskiy nauchnyy meditsinskiy vestnik. 2012; (3): 98–100. Available at: https://cyberleninka.ru/article/n/sopostavlenie-mikroflory-zeva-i-mokroty-u-bolnyh-s-infektsiyami-respiratornoy-sistemy (in Russian).
49. Malykhin F.T., Baturin V.A., Shchetinin E.V. [Regional characteristics of the changing nature of microflora of sputum in chronic obstructive pulmonary disease in patients of different age groups]. Zabaykal’skiy meditsinskiy vestnik. 2017; (4): 33–40. Available at: http://zabmedvestnik.ru/arhiv-nomerov/nomer-4-za-2017-god/regionalnye-osobennosti-izmenenija-haraktera-mikroflory-mokroty-pri-hronicheskoj-obstruktivnoj-bolezni-legkih-u-pacientov-raznyh-vozrastnyh-grupp (in Russian).
50. Leynaert B., Bousquet J., Henry C. et al. Is bronchial hyperresponsiveness more frequent in women than in men? A population-based study. Am. J. Respir. Crit. Care Med. 1997; 156 (5): 1413–1420. DOI: 10.1164/ajrccm.156.5.9701060.
51. Ghebre M.A., Bafadhel M., Desai D. et al. Biological clustering supports both “Dutch” and “British” hypotheses of asthma and chronic obstructive pulmonary disease. J. Allergy Clin. Immunol. 2015; 135 (1): 63–72. DOI: 10.1016/j.jaci.2014.06.035.
52. Elias J. The relationship between asthma and COPD. Lessons from transgenic mice. Chest. 2004; 126 (2, Suppl.): 111–116S. DOI: 10.1378/chest.126.2_suppl_1.111S.
53. Celli B., Vestbo J., Jenkins C.R. et al. Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience. Am. J. Respir. Crit. Care Med. 2011; 183 (3): 317–322. DOI: 10.1164/rccm.201004-0665OC.
54. Papaioannou A.I., Bania E., Alexopoulos E.C. et al. Sex discrepancies in COPD patients and burden of the disease in females: a nationwide study in Greece (Greek Obstructive Lung Disease Epidemiology and health ecoNomics: GOLDEN study). Int. J. Chron. Obstruct. Pulmon. Dis. 2014; 9 (1): 203–213. DOI: 10.2147/COPD.S52500.
55. Roche N., Deslee G., Caillaud D. et al. Impact of gender on COPD expression in a real-life cohort. Respir. Res. 2014; 15 (1): 20. DOI: 10.1186/1465-9921-15-20.
56. Foreman M.G., Zhang L., Murphy J. et al. Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene study. Am. J. Respir. Crit. Care Med. 2011; 184 (4): 414–420. DOI: 10.1164/rccm.201011-1928OC.
57. Camp P.G., Coxson H.O., Levy R.D. et al. Sex differences in emphysema and airway disease in smokers. Chest. 2009; 136 (6): 1480–1488. DOI: 10.1378/chest.09-0676.
58. Han M.K., Kazerooni E.A., Lynch D.A. et al. Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology. 2011; 261 (1): 274–282. DOI: 10.1148/radiol.11110173.
59. Malykhin F.T. [Age-related characteristics of the bronchi and lungs in the elderly and senile people]. Morfologiya. 2019; 155 (1): 66–72 (in Russian).
60. Chernyaev A.L., Samsonova M.V. [Pathological anatomy of the lungs. Atlas]. 2nd ed. Moscow: Atmosphere; 2011 (in Russian)
Review
For citations:
Malykhin F.T. Typical features of the etiology, pathogenesis and pathological morphology of chronic obstructive pulmonary disease in women and men. PULMONOLOGIYA. 2021;31(4):530-536. (In Russ.) https://doi.org/10.18093/0869-0189-2021-31-4-530-536
Views:
1020
Email this article 